Activities of Ertapenem, a New Long-Acting Carbapenem, against Penicillin-Sensitive or -Resistant Pneumococci in Experimental Meningitis

The penetration of ertapenem, a new carbapenem with a long half-life, reached 7.1 and 2.4% into inflamed and noninflamed meninges, respectively. Ertapenem had excellent antibacterial activity in the treatment of experimental meningitis due to penicillin-sensitive and -resistant pneumococci, leading...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Cottagnoud, P., Pfister, M., Cottagnoud, M., Acosta, F., Täuber, M. G.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC155819/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12760871/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.6.1943-1947.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!